SEC 13F Intelligence

Pembroke Management, Ltd / GMED

Pembroke Management, Ltd’s Globus Med Inc Position

Does Pembroke Management, Ltd own Globus Med Inc (GMED)? Yes408.5K shares worth $35M (+5.09% of its 13F portfolio) as of Q1 2026, down from 569.7K shares the prior filed quarter.

Position Value
$35M
Q1 2026
Shares
408.5K
% of Portfolio
+5.09%
Quarters Held
28
currently held

Position History GMED

Reported value by quarter
Q2 ’19: $13MQ2 ’19Q3 ’19: $19MQ4 ’19: $20MQ1 ’20: $21MQ2 ’20: $23MQ2 ’20Q3 ’20: $24MQ4 ’20: $40MQ1 ’21: $38MQ2 ’21: $47MQ2 ’21Q3 ’21: $46MQ4 ’21: $43MQ1 ’22: $45MQ2 ’22: $34MQ2 ’22Q3 ’22: $35MQ4 ’22: $43MQ1 ’23: $31MQ2 ’23: $36MQ2 ’23Q3 ’23: $30MQ4 ’23: $32MQ1 ’24: $34MQ2 ’24: $40MQ2 ’24Q3 ’24: $41MQ4 ’24: $46MQ1 ’25: $39MQ2 ’25: $35MQ2 ’25Q3 ’25: $32MQ4 ’25: $50MQ1 ’26: $35Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026408.5K$35M+5.09%
Q4 2025569.7K$50M+5.14%
Q3 2025562.2K$32M+3.19%
Q2 2025600.9K$35M+4.29%
Q1 2025533.4K$39M+5.69%
Q4 2024559.9K$46M+5.77%
Q3 2024568.7K$41M+5.19%
Q2 2024587.6K$40M+5.41%
Q1 2024626.6K$34M+3.95%
Q4 2023595.9K$32M+3.94%
Q3 2023603.4K$30M+4.09%
Q2 2023604.9K$36M+3.88%
Q1 2023546.8K$31M+3.39%
Q4 2022584.1K$43M+4.64%
Q3 2022590.8K$35M+3.91%
Q2 2022600.1K$34M+3.48%
Q1 2022603.4K$45M+3.72%
Q4 2021602.4K$43M+3.19%
Q3 2021601.4K$46M+3.47%
Q2 2021600.3K$47M+3.65%
Q1 2021614.8K$38M+3.15%
Q4 2020613.9K$40M+3.36%
Q3 2020490.9K$24M+2.65%
Q2 2020483.3K$23M+2.71%
Q1 2020488.4K$21M+3.30%
Q4 2019337.9K$20M+1.69%
Q3 2019369.6K$19M+2.06%
Q2 2019319.0K$13M+1.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pembroke Management, Ltd’s full portfolio or all institutional holders of GMED.